Clinical trial
Efficacy and Safety of the XEN63: a Prospective Observational Multicenter Study.
NCT06844240 is registered in ClinicalTrials.gov with Mario Stirpe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of the XEN63: a Prospective Observational Multicenter Study.
- Lead sponsor
- Mario Stirpe
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- November 28, 2024
- Completion date
- December 31, 2030
- Enrollment
- 96 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.